/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Vima Therapeutics

Vima Therapeutics

United States

Vima Therapeutics is developing a novel oral therapy designed to help patients regain control of their movement, specifically for people living with dystonia and Parkinson’s disease.

Healthcare & Biotech

Vima Therapeutics, based in United States, has 2 investors on file, among them Atlas Venture and Frazier Life Sciences. Its latest round on record is Series A, 13 Mar 2026. Its site was last checked 13 Nov 2026: site answers.

vimatx.com

Funding

1 round on record
Latest roundSeries A13 Mar 2026
Since that round8 monthsno later round on record
Investors in its rounds11 with a VCinfo profile
Mar 2026Series AWith Frazier Life Sciences

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

2 investors on file
InvestorEvidenceType
Atlas VenturePortfolio pageVenture capital
Frazier Life SciencesPage + roundVenture capital

More from Atlas Venture

52 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (93%), Industrial & Manufacturing (2%), Robotics & Hardware (2%).

Accent TherapeuticsAccent Therapeutics develops small molecule therapeutics for patients …Alnylam PharmaceuticalsAlnylam Pharmaceuticals develops RNAi therapeutics.Bicycle TherapeuticsBicycle Therapeutics is developing precision-guided therapeutics to ta…Cogent BiosciencesCogent Biosciences conducts clinical trials and develops treatments fo…ComancheComanche Biopharma is a biopharmaceutical company developing an invest…

See Atlas Venture's full profile · Who invests alongside it

More from Frazier Life Sciences

78 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (99%), Food & Agriculture (1%).

Amicus TherapeuticsAmicus Therapeutics is a subsidiary of BioMarin Pharmaceutical Inc. fo…AnaptysBioAnaptysBio manages financial collaborations with pharmaceutical compan…Angitia BioAngitia Biopharmaceuticals is a clinical-stage biotechnology company f…ArcutisArcutis Biotherapeutics develops targeted therapies for chronic immune…Aspen NeuroscienceAspen Neuroscience develops personalized cell therapies for Parkinson'…

See Frazier Life Sciences' full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Vima Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Atlas Venture adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/vimatx.com/investors

# also
GET /v1/companies/vimatx.com
GET /v1/companies/vimatx.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing